At HIMSS23, Mark Zandi, Chief Economist and Co-Founder of Moody’s Analytics, discussed the possibility of an economic recession. He noted that while there are significant risks, such as inflation and the potential for failing…
Continue Reading
What You Should Know:2023 started off with the hallmarks of a rebound year. While Q4 2022 signaled the tail end of the digital health funding cycle, January and February funding numbers began to suggest…
Continue Reading
The following is a guest article by Dmitrii Evstiukhin, Director of Managed Services at Provectus
In today’s world, personalized and efficient digital interactions are expected, especially in the healthcare industry. To meet those demands, organizations…
By Sara Heath March 16, 2023 – The affordable housing crisis might impact patient health, with new data from the UCLA David Geffen School of Medicine showing that moving because rent gets…
Continue Reading
In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient […]
Continue Reading In todays fast-paced world, it is easy to miss out on important information, especially if you are trying to keep up with a lot of different sources. That is where the daily digest comes in – it is a tool that compiles all the posts created on the previous day, providing you with a convenient […]
Continue Reading
dial
A perfect storm of external and internal factors has combined to worsen an already dire nursing shortage nationwide, particularly in the field of nephrology: a rapidly aging population and workforce, increased levels of burnout…
AbbVie, Gilead Sciences, Pfizer, and Roche are among the companies that must cut a check to the U.S. government. Those companies have Medicare-covered medicines whose prices rose faster than inflation and according to a…
Continue Reading
The telehealth flexibilities allowed during the Covid-19 public health emergency greatly expanded access to healthcare services. But after the public health emergency ends, it’s ultimately up to Congress to further extend these flexibilities, said…
Continue Reading
Novo Nordisk is slashing prices of several insulin products by up to 75% amid growing political scrutiny on the prices of these older but still expensive diabetes medicines. The announcement Tuesday comes two weeks…
Continue Reading
